MedPath

Can minocycline reverse morphine-induced respiratory depression in obstructive sleep apnea patients?- A pilot study

Phase 1
Recruiting
Conditions
obstructive sleep apnea
Respiratory - Sleep apnoea
Registration Number
ACTRN12610001074088
Lead Sponsor
HMRC Training Fellowship
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
10
Inclusion Criteria

Aged between 18-60 years who have previously been tested by a polysomnography (PSG) study that shows they have sleep apnoea, with Apnea Hypopnea Index >15/hr and SpO2 nadir 90-70%.

Exclusion Criteria

1. History of adverse effects from opioids or minocycline. 2. History of drug abuse. 3. Regular use of opiates. 4. Current or recent severe physiological or psychological illness including severe cardiovascular (hypertension) or CNS diseases. 5. Presence of another severe sleep disorders (such as period limb movement disorders or shift work sleep disorder). 6. Concurrent using CPAP or taking of other medications which might interfere with the study drugs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SpO2 (Oxygen Saturation) nadir during sleep[at two cross-over polysomnography (PSG) nights and at screening (baseline) PSG night];%Total sleep time SpO2 <90% during sleep. The parameter is part of the PSG measurement.[at two cross-over PSG nights and at screening (baseline) PSG night];Central chemosensitivity tested by ventilatory chemoreflex tesing system[at two cross-over PSG evenings during awake and at screening (baseline) examination]
Secondary Outcome Measures
NameTimeMethod
Oxygen desaturation index (ODI) as part of PSG assessment[at two cross-over PSG nights and at screening (baseline) PSG night];CO2 recruitment threshold tested by chemoreflex testing system[at two cross-over PSG evenings during awake and at screening (baseline) examination];Pain threshold (Mechanical Detection Threshold) tested by Von Frey Hair[at two cross-over PSG evenings during awake]
© Copyright 2025. All Rights Reserved by MedPath